Global Pharmaceutical Compliance

Venue: New York City

Location: New York City, United States

Event Date/Time: Jun 27, 2005
Report as Spam


Despite the good intentions of mandates such as the California law, a compliance program based on the Code and/or Guidance alone is not sufficient to deal with the complexities of today’s global market. The Code and the Guidance only address fraud and abuse in sales and marketing practices and pricing fraud. However, doing business in a global market dictates that many other matters such as FCPA violations, export controls, medical affairs, clinical trials, SOX obligations, government contracting and cGMPs now be incorporated into a larger infrastructure of global compliance. Increased scrutiny by government prosecutors and regulators in such matters has also added to this urgency and necessity.

Today, it is absolutely critical that pharmaceutical compliance executives and in-house counsel as well as those who advise them have a strong understanding of compliance obligations on a global scale and the strategies to fulfill them. They must have the competency to develop a comprehensive and thorough compliance program that covers all corporate, international and regulatory areas.

American Conference Institute has created this comprehensive program to provide you with an in-depth understanding of the infrastructure of a global compliance program and areas in which compliance cannot be ignored. A faculty of leading in-house counsel and compliance officers and leading attorneys will bring you the most up-to-date information on various topics.